Cargando…
Dexmedetomidine Attenuates Apoptosis and Neurological Deficits by Modulating Neuronal NADPH Oxidase 2-Derived Oxidative Stress in Neonates Following Hypoxic Brain Injury
Hypoxic–ischemic brain injury is an important cause of neonatal neurological deficits. Our previous study demonstrated that dexmedetomidine (Dex) provided neuroprotection against neonatal hypoxic brain injury; however, the underlying mechanisms remain incompletely elucidated. Overactivation of NADPH...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686745/ https://www.ncbi.nlm.nih.gov/pubmed/36358571 http://dx.doi.org/10.3390/antiox11112199 |
_version_ | 1784835829641773056 |
---|---|
author | Chen, Xiaohui Chen, Dongtai Chen, Pinzhong Chen, Andi Deng, Jianhui Wei, Jianjie Zeng, Weian Zheng, Xiaochun |
author_facet | Chen, Xiaohui Chen, Dongtai Chen, Pinzhong Chen, Andi Deng, Jianhui Wei, Jianjie Zeng, Weian Zheng, Xiaochun |
author_sort | Chen, Xiaohui |
collection | PubMed |
description | Hypoxic–ischemic brain injury is an important cause of neonatal neurological deficits. Our previous study demonstrated that dexmedetomidine (Dex) provided neuroprotection against neonatal hypoxic brain injury; however, the underlying mechanisms remain incompletely elucidated. Overactivation of NADPH oxidase 2 (NOX2) can cause neuronal apoptosis and neurological deficits. Hence, we aimed to investigate the role of neuronal NOX2 in Dex-mediated neuroprotection and to explore its potential mechanisms. Hypoxic injury was modeled in neonatal rodents in vivo and in cultured hippocampal neurons in vitro. Our results showed that pre- or post-treatment with Dex improved the neurological deficits and alleviated the hippocampal neuronal damage and apoptosis caused by neonatal hypoxia. In addition, Dex treatment significantly suppressed hypoxia-induced neuronal NOX2 activation; it also reduced oxidative stress, as evidenced by decreases in intracellular reactive oxygen species (ROS) production, malondialdehyde, and 8-hydroxy-2-deoxyguanosine, as well as increases in the antioxidant enzymatic activity of superoxide dismutase and glutathione peroxidase in neonatal rat hippocampi and in hippocampal neurons. Lastly, the posthypoxicneuroprotective action of Dex was almost completely abolished in NOX2-deficient neonatal mice and NOX2-knockdown neurons. In conclusion, our data demonstrated that neuronal NOX2-mediated oxidative stress is involved in the neuroprotection that Dex provides against apoptosis and neurological deficits in neonates following hypoxia. |
format | Online Article Text |
id | pubmed-9686745 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96867452022-11-25 Dexmedetomidine Attenuates Apoptosis and Neurological Deficits by Modulating Neuronal NADPH Oxidase 2-Derived Oxidative Stress in Neonates Following Hypoxic Brain Injury Chen, Xiaohui Chen, Dongtai Chen, Pinzhong Chen, Andi Deng, Jianhui Wei, Jianjie Zeng, Weian Zheng, Xiaochun Antioxidants (Basel) Article Hypoxic–ischemic brain injury is an important cause of neonatal neurological deficits. Our previous study demonstrated that dexmedetomidine (Dex) provided neuroprotection against neonatal hypoxic brain injury; however, the underlying mechanisms remain incompletely elucidated. Overactivation of NADPH oxidase 2 (NOX2) can cause neuronal apoptosis and neurological deficits. Hence, we aimed to investigate the role of neuronal NOX2 in Dex-mediated neuroprotection and to explore its potential mechanisms. Hypoxic injury was modeled in neonatal rodents in vivo and in cultured hippocampal neurons in vitro. Our results showed that pre- or post-treatment with Dex improved the neurological deficits and alleviated the hippocampal neuronal damage and apoptosis caused by neonatal hypoxia. In addition, Dex treatment significantly suppressed hypoxia-induced neuronal NOX2 activation; it also reduced oxidative stress, as evidenced by decreases in intracellular reactive oxygen species (ROS) production, malondialdehyde, and 8-hydroxy-2-deoxyguanosine, as well as increases in the antioxidant enzymatic activity of superoxide dismutase and glutathione peroxidase in neonatal rat hippocampi and in hippocampal neurons. Lastly, the posthypoxicneuroprotective action of Dex was almost completely abolished in NOX2-deficient neonatal mice and NOX2-knockdown neurons. In conclusion, our data demonstrated that neuronal NOX2-mediated oxidative stress is involved in the neuroprotection that Dex provides against apoptosis and neurological deficits in neonates following hypoxia. MDPI 2022-11-07 /pmc/articles/PMC9686745/ /pubmed/36358571 http://dx.doi.org/10.3390/antiox11112199 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Chen, Xiaohui Chen, Dongtai Chen, Pinzhong Chen, Andi Deng, Jianhui Wei, Jianjie Zeng, Weian Zheng, Xiaochun Dexmedetomidine Attenuates Apoptosis and Neurological Deficits by Modulating Neuronal NADPH Oxidase 2-Derived Oxidative Stress in Neonates Following Hypoxic Brain Injury |
title | Dexmedetomidine Attenuates Apoptosis and Neurological Deficits by Modulating Neuronal NADPH Oxidase 2-Derived Oxidative Stress in Neonates Following Hypoxic Brain Injury |
title_full | Dexmedetomidine Attenuates Apoptosis and Neurological Deficits by Modulating Neuronal NADPH Oxidase 2-Derived Oxidative Stress in Neonates Following Hypoxic Brain Injury |
title_fullStr | Dexmedetomidine Attenuates Apoptosis and Neurological Deficits by Modulating Neuronal NADPH Oxidase 2-Derived Oxidative Stress in Neonates Following Hypoxic Brain Injury |
title_full_unstemmed | Dexmedetomidine Attenuates Apoptosis and Neurological Deficits by Modulating Neuronal NADPH Oxidase 2-Derived Oxidative Stress in Neonates Following Hypoxic Brain Injury |
title_short | Dexmedetomidine Attenuates Apoptosis and Neurological Deficits by Modulating Neuronal NADPH Oxidase 2-Derived Oxidative Stress in Neonates Following Hypoxic Brain Injury |
title_sort | dexmedetomidine attenuates apoptosis and neurological deficits by modulating neuronal nadph oxidase 2-derived oxidative stress in neonates following hypoxic brain injury |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686745/ https://www.ncbi.nlm.nih.gov/pubmed/36358571 http://dx.doi.org/10.3390/antiox11112199 |
work_keys_str_mv | AT chenxiaohui dexmedetomidineattenuatesapoptosisandneurologicaldeficitsbymodulatingneuronalnadphoxidase2derivedoxidativestressinneonatesfollowinghypoxicbraininjury AT chendongtai dexmedetomidineattenuatesapoptosisandneurologicaldeficitsbymodulatingneuronalnadphoxidase2derivedoxidativestressinneonatesfollowinghypoxicbraininjury AT chenpinzhong dexmedetomidineattenuatesapoptosisandneurologicaldeficitsbymodulatingneuronalnadphoxidase2derivedoxidativestressinneonatesfollowinghypoxicbraininjury AT chenandi dexmedetomidineattenuatesapoptosisandneurologicaldeficitsbymodulatingneuronalnadphoxidase2derivedoxidativestressinneonatesfollowinghypoxicbraininjury AT dengjianhui dexmedetomidineattenuatesapoptosisandneurologicaldeficitsbymodulatingneuronalnadphoxidase2derivedoxidativestressinneonatesfollowinghypoxicbraininjury AT weijianjie dexmedetomidineattenuatesapoptosisandneurologicaldeficitsbymodulatingneuronalnadphoxidase2derivedoxidativestressinneonatesfollowinghypoxicbraininjury AT zengweian dexmedetomidineattenuatesapoptosisandneurologicaldeficitsbymodulatingneuronalnadphoxidase2derivedoxidativestressinneonatesfollowinghypoxicbraininjury AT zhengxiaochun dexmedetomidineattenuatesapoptosisandneurologicaldeficitsbymodulatingneuronalnadphoxidase2derivedoxidativestressinneonatesfollowinghypoxicbraininjury |